US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist
  • 2.250
  • -0.300-11.76%
Close Dec 13 16:00 ET
  • 2.240
  • -0.010-0.44%
Post 20:01 ET
443.33MMarket Cap-3.36P/E (TTM)

Esperion Therapeutics Key Stats

Esperion Therapeutics Q3 2024 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
51.71M
51.63M
-81.62K
Miss Est.
+52.24%
+52.00%
-0.16%
EPS
-0.18
-0.15
+0.03
Beat Est.
+52.64%
+59.46%
+14.38%
Buy

Dec 11, 2024

Esperion Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 60.800M--
--2024/Q4-- / 61.555M--
Nov 7, 20242024/Q351.632M / 51.714M--
Aug 12, 20242024/Q273.834M / 47.500M--
May 7, 20242024/Q1137.735M / 83.888M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 60.800M--
--2024/Q4-- / 61.555M--
Nov 7, 20242024/Q351.632M / 51.714M--
Aug 12, 20242024/Q273.834M / 47.500M--
May 7, 20242024/Q1137.735M / 83.888M--

Unlock Free Earnings Estimates

Esperion Therapeutics Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 11, 2024

Buy

  • Buy

    80.00%
  • Hold

    0.00%
  • Sell

    20.00%

Price Target

No Data